Research Fellow ๐ฉโโ๏ธ๐ฌ๐ฎ๐น @UNIVPM Prof.Montironi's Lab Uropathologist- Member of EAU-YAU Urothelial Cancer Working Party
Ancona, IT
Joined December 2011
- Tweets111
- Following290
- Followers305
- Likes568
Alessia Cimadamore retweeted
๐ข Join us at #USCAP2026 in San Antonio!
๐๏ธ Sun, Mar 22 | ๐ Stars at Night Ballroom B2
๐ ISUP AGM and Awards: 1:30โ2:00 PM
๐ Companion Society Mtg: 2:00โ4:00 PM
๐ฌ Foundations and the Future in Urologic Pathologyย ๐
Alessia Cimadamore retweeted
Florence Welcomes You! Please join us for this important Multidisciplinary Consensus Conference on Cancer Precursor Lesions of the Genitourinary Organs on September 12, 2024. The final program is now available here: isupweb.org/isup/events/
A few slots are still available, you may register for the meeting using this link:
isup-italy-2024.eventbrite.cโฆ
ย
We look forward to seeing you next week in most beautiful Firenze!ย
@IntSocUropath
@virchow
@MuraliV72899596
@AlessiaCim
@rovingatuscap
@ro36693000
@GladellPaner
@Williamson_SR
@katcollmd
@GUpathMenon
Alessia Cimadamore retweeted
#ISUP Upcoming Event
2024 ISUP Italy Multidisciplinary Consensus Conference on Precursor Lesions of Genitourinary Organs #ISUPItaly2024 ๐ฎ๐น
๐
12 Sept 2024, immediately following @ESP_Pathology #ECPItaly2024
Register here:
ISUP-ITALY-2024.eventbrite.cโฆ
Alessia Cimadamore retweeted
๐ข Glad to share our collaborative review on prognostic significance of Histological #Subtypes in #MIBC across either surgical or bladder sparing treatments
Just released on @JCM_MDPI ๐
mdpi.com/2885444
Alessia Cimadamore retweeted
Are you looking for answers to the 10 most common questions about prostate cancer grading? ย
- Check out the latest article published in Virchows Archivย @ESP_Pathology. This must-read paper is essential for all pathologists, urologists, and oncologists in training. Kudos to Alessia @AlessiaCim, Antonio, Carmine, Gianluca @GGiannarini, Alessandro, Eamonn, and Rodolfo for this beautiful work.
link.springer.com/article/10โฆ
Inspiring presentation on targeted therapies on the horizon in mUC by the most enthusiastic oncologist in the world! @PGrivasMDPhD โ at Malaga, Spain
Alessia Cimadamore retweeted
๐ซ๐๐ Multidisciplinary young academics session: Future management of T2N0M0 Urothelial Carcinoma.
#BLADDR23 @OncoAlert @mirrorsmed @IBCG_BladderCA @BladderCancerUS @WorldBladderCan
Moderators Laura Mertens & @UroMoschini, featuring a
๐ฏPathologistโs perspective by @AlessiaCim.
๐ฉโ๐A beautiful presentation, highly educationalโa journey through bladder cancer histology and markers. #UCa #MedicalEducation #YoungAcademics
Alessia Cimadamore retweeted
Fantastic presentation by @AlessiaCim on histology variants & clinical implications in MIBC! Opportunities for molecular subtypes & IHC for ADC use require prospective testing to assess clinical utility! @JoshMeeks @achoud72 @koshkin85 @OncoAlert #BLADD23 @mirrorsmed @FaltasLab
Excellent presentation by @PaulSargos on TMT for localized MIBC! Patients should be counseled! Agree that multiD strategy is key! We published with @LDiamantMD @JLWrightMD
content.iospress.com/articleโฆ
@mirrorsmed @OncoAlert @achoud72 @spsutkaMD @mouwlab @DrOmarMian @koshkin85
Alessia Cimadamore retweeted
Stellar talk by @DanieleRaggi83 covering opportunities for drug development in MIBC with (neo)adjuvant strategies & need for composite biomarkers! Many Impressive trials in his center! @OncoAlert @AndreaNecchi #BLADDR23 @SanRaffaeleMI @AlessiaCim @achoud72 @koshkin85 @mirrorsmed
Alessia Cimadamore retweeted
Un percorso per i nostri pazienti @AssPalinuro , per facilitare lโaccesso a cure seguendo le linee guida @Uroweb #instillazione #robotica #eras #mdt @EAU_YAUrotheli
Al Policlinico Tor Vergata si apre un nuovo percorso diagnostico terapeutico assistenziale (PDTA) per i pazienti affetti da tumore alla vescica.
@MinisteroSalute @SaluteLazio @unitorvergata @EFinazziAgro @albisinnidoc
lazioinsalute.it/2023/11/15/โฆ
Alessia Cimadamore retweeted
The 2023 #ISUP Consensus Conference on the Best Practice Recommendations on the Pathology of #Urachal Neoplasms and Glandular Lesions of the Urinary #Bladder
Itโs a complete success! Thank you all!#GUPath @IntSocUropath @henning_reis @Isabelawcunha @FionaMacPath @h_alahmadie โ at Dublin City, Ireland
Alessia Cimadamore retweeted
#EAU23 great start this morning with the #YAU session! Some postcards:
โข@Cacciamani_MD brilliantly summarising the efforts by #oncology/ #tech groups
โขMyself receiving Best #Reviewer ๐
#Award, and giving a lecture about prediction of response to #immunotherapy in #kidneycancer
Alessia Cimadamore retweeted
Definitely, The thanks go to the amazing mentor @LiangChengMD and incredible team @SaleebRola
@Kiril_T_Can @Williamson_SR @slusagar @AlessiaCim
@Andres_M_Acosta @ZainabAlruwaii @AhmadElkashash #gupath @TheUSCAP #pathTwitter
Alessia Cimadamore retweeted
EAU-YAU Urothelial Carcinoma working group is the best! Thank you @UroMoschini for leading us!! ๐๐๐#EAU22
My First #EAU22! so nice to meet friends and collegues in person sharing thoughts and projects! Happy to be involved in such a great community! @EAU_YAUrotheli @eau_yuo ๐ช#uropathology โ at Amsterdam, The Netherlands
Alessia Cimadamore retweeted
Just published in May issue @ESP_Pathology
Congratulations!! Prof Lopez-Beltran, @AlessiaCim and colleagues
T1 #bladdercancer with variant histology: pubmed.ncbi.nlm.nih.gov/3512โฆ
#urology #oncology #gupath
Alessia Cimadamore retweeted
Does everyone with advanced ccRCC need combo tx? Can we save combo toxicity for those who need it? What biomarkers predict PD-1i sensitivity or CTLA4i/PD-1i sensitivity? Now in @JCO_ASCO, the @hoosiercancer HCRN GU16-260 study (Cohort A--clear cell): ascopubs.org/doi/full/10.120โฆ
Alessia Cimadamore retweeted
Thanks to our patients, their families, and the @kidneycancer community. Co-authors @bilenma @ERPlimackMD @MosheOrnsteinMD @anotherpathres @AlessiaCim @BraunMDPhD @HHammersMD @dfcidatascience and many more not on Twitter.
Alessia Cimadamore retweeted
Risk assoc with variant histology in HGT1 bladder carcinoma compared with conventional urothelial carcinoma and other aspects to consider when reporting percentages of variant histology
#gupath #pathtwitter
๐ link.springer.com/article/10โฆ
@AlessiaCim @LiangChengMD @ESP_Pathology
